| Primary |
| Hiv Infection |
50.5% |
| Acquired Immunodeficiency Syndrome |
18.5% |
| Diabetes Mellitus |
4.8% |
| Drug Use For Unknown Indication |
3.7% |
| Cancer Pain |
2.8% |
| Mycobacterium Avium Complex Infection |
2.0% |
| Factor Viii Deficiency |
1.7% |
| Insomnia |
1.6% |
| Perirectal Abscess |
1.6% |
| Eczema |
1.5% |
| Antifungal Prophylaxis |
1.4% |
| Antiviral Treatment |
1.4% |
| Chronic Hepatitis C |
1.4% |
| Gastric Ulcer |
1.2% |
| Antiretroviral Therapy |
1.1% |
| Hypertension |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Tuberculosis |
1.1% |
| Oral Candidiasis |
0.9% |
| Rash |
0.7% |
|
| Rash |
13.8% |
| Vomiting |
10.0% |
| Pyrexia |
8.8% |
| Drug Exposure During Pregnancy |
6.3% |
| Lymphoma |
6.3% |
| Paraesthesia Oral |
6.3% |
| Rectal Cancer |
6.3% |
| Weight Decreased |
5.0% |
| Abortion Spontaneous |
3.8% |
| Cardiac Arrest |
3.8% |
| Diarrhoea |
3.8% |
| Drug Ineffective |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Viral Load Increased |
3.8% |
| Abdominal Discomfort |
2.5% |
| Abdominal Pain Upper |
2.5% |
| Blood Glucose Increased |
2.5% |
| Blood Triglycerides Increased |
2.5% |
| Death |
2.5% |
| Diabetes Mellitus Non-insulin-dependent |
2.5% |
|
| Secondary |
| Hiv Infection |
56.7% |
| Acquired Immunodeficiency Syndrome |
9.1% |
| Drug Exposure During Pregnancy |
8.0% |
| Drug Use For Unknown Indication |
5.7% |
| Product Used For Unknown Indication |
5.0% |
| Antiretroviral Therapy |
2.8% |
| Insomnia |
2.6% |
| Antiviral Treatment |
1.7% |
| Chronic Hepatitis C |
1.7% |
| Diarrhoea |
0.9% |
| Tuberculosis |
0.8% |
| Abdominal Discomfort |
0.6% |
| Antiviral Prophylaxis |
0.6% |
| Factor Viii Deficiency |
0.6% |
| Herpes Zoster |
0.6% |
| Systemic Antiviral Treatment |
0.6% |
| Diabetes Mellitus |
0.5% |
| Hypertension |
0.5% |
| Antifungal Prophylaxis |
0.5% |
| Schizophrenia |
0.5% |
|
| Vitamin B12 Deficiency |
13.6% |
| Rash |
10.9% |
| Osteoma |
6.4% |
| Premature Baby |
6.4% |
| Foetal Cardiac Disorder |
5.5% |
| Drug Exposure During Pregnancy |
4.5% |
| Herpes Zoster |
4.5% |
| Micrognathia |
4.5% |
| Subacute Combined Cord Degeneration |
4.5% |
| Subcutaneous Abscess |
4.5% |
| Talipes |
4.5% |
| Vomiting |
4.5% |
| Diarrhoea |
3.6% |
| Myocardial Infarction |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Trisomy 21 |
3.6% |
| Facial Wasting |
2.7% |
| Lymphoma |
2.7% |
| Pneumonia |
2.7% |
| Pyrexia |
2.7% |
|
| Concomitant |
| Hiv Infection |
56.6% |
| Drug Use For Unknown Indication |
11.0% |
| Product Used For Unknown Indication |
4.5% |
| Hypertension |
3.6% |
| Hepatitis C |
2.9% |
| Acquired Immunodeficiency Syndrome |
2.7% |
| Antifungal Prophylaxis |
2.0% |
| Hyperlipidaemia |
2.0% |
| Depression |
1.8% |
| Myocardial Infarction |
1.8% |
| Factor Viii Deficiency |
1.6% |
| Antacid Therapy |
1.4% |
| Pulmonary Arterial Hypertension |
1.4% |
| Prophylaxis |
1.2% |
| Anxiety |
1.0% |
| Cytomegalovirus Chorioretinitis |
1.0% |
| Nausea |
1.0% |
| Hiv Test Positive |
0.9% |
| Insomnia |
0.8% |
| Pain |
0.8% |
|
| Rash |
9.8% |
| Vomiting |
9.8% |
| Premature Labour |
7.8% |
| Nausea |
5.9% |
| Ultrasound Antenatal Screen Abnormal |
5.9% |
| Abortion Spontaneous |
4.9% |
| Alopecia |
4.9% |
| Pregnancy |
4.9% |
| Renal Failure Acute |
4.9% |
| Varices Oesophageal |
4.9% |
| Weight Decreased |
4.9% |
| Bronchitis |
3.9% |
| Cardiomyopathy |
3.9% |
| Immune Reconstitution Syndrome |
3.9% |
| Rash Generalised |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Angina Unstable |
2.9% |
| Diffuse Large B-cell Lymphoma |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Hepatitis C |
2.9% |
|
